Sartorius | SRT3 - Assets

Stock Price
205.80
Daily Change
-3.90 -1.86%
Monthly
-8.78%
Yearly
-16.85%
Q1 Forecast
203.68

Sartorius reported EUR9.61B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Akebia Therapeutics USD 376.56M 12.41M Dec/2025
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
Avita Medical AUD 56.39M 1.74M Dec/2025
Dianthus Therapeutics USD 530.92M 46.52M Dec/2025
Ionis Pharmaceuticals USD 3.52B 490.91M Dec/2025
IQVIA Holdings USD 29.94B 1.22B Dec/2025
Moderna USD 12.34B 203M Dec/2025
Organon & Co USD 13.55B 52M Sep/2025
Revvity USD 12.17B 29.46M Dec/2025
Sartorius EUR 9.61B 413.4M Sep/2025
Tectonic Therapeutic USD 277M 18.31M Sep/2025
Viatris USD 37.19B 727.3M Dec/2025
Xeris Pharmaceuticals USD 370.19M 35.5M Sep/2025